Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study
- PMID: 36417400
- PMCID: PMC9683564
- DOI: 10.1371/journal.pone.0277536
Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study
Abstract
Background: Consistently deciding its current extent and chance elements of tuberculosis (TB) in all levels of clinical settings contributes to the anticipation and control exertion of the disease. In Ethiopia, updated information is still needed at every healthcare level and in different risk groups to monitor the national program's performance, which aims to attain the 2035 goal. Hence, this study aimed to generate additional evidence data on the magnitude of Mycobacterium tuberculosis using the Gene Xpert assay among TB-suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia.
Methods: A cross-sectional descriptive study was conducted from June to September 30, 2021. The required socio-demographic and other risk factor data were collected from a total of 422 suspected TB patients using a structured questionnaire. Approximately 392 pulmonary and 30 extra-pulmonary samples were collected and examined using the Gene Xpert-MTB/RIF assay. The statistical package for social sciences (SPSS) version 25 software was used to analyze the data.
Results: In this study, Mycobacterium tuberculosis was detected in 12.5% (49/392) of pulmonary samples and 13.3% (4/30) of extra-pulmonary samples, giving an overall TB positivity of 12.6% (53/422). Rifampicin-resistant M. tuberculosis was detected in 3/53 (5.7%). Male sex (AOR: 2.54; 95% CI: 1.210, 5.354), previous contact (AOR: 4.25; 95% CI: 1.790, 10.092), smoking cigarette (AOR: 4.708; 95% CI: 1.004, 22.081), being HIV-positive (AOR: 4.27; 95% CI: 1.606, 11.344), and malnutrition (AOR: 3.55; 95% CI: 1.175, 10.747) were all significantly associated with M. tuberculosis detection using the GeneXpert MTB/RIF assay.
Conclusion: The overall frequency of M. tuberculosis in this study was still significant in different risk groups, despite the proposed strategies, which aimed to reduce TB prevalence to as low as 10 per 100,000 populations by 2035. Early case detection with better diagnostic tools and public health measures are important prevention and control strategies to meet the proposed target and reduce the burden of TB in the country.
Copyright: © 2022 Abayneh, Teressa. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.BMC Res Notes. 2017 Jan 3;10(1):8. doi: 10.1186/s13104-016-2328-4. BMC Res Notes. 2017. PMID: 28057041 Free PMC article.
-
The prevalence of Mycobacterium tuberculosis using Gene Xpert among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia.Eur J Med Res. 2022 Feb 12;27(1):24. doi: 10.1186/s40001-022-00650-x. Eur J Med Res. 2022. PMID: 35151350 Free PMC article.
-
High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia.PLoS One. 2022 Dec 30;17(12):e0277145. doi: 10.1371/journal.pone.0277145. eCollection 2022. PLoS One. 2022. PMID: 36584037 Free PMC article.
-
Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis.Heliyon. 2023 Aug 28;9(9):e19554. doi: 10.1016/j.heliyon.2023.e19554. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809604 Free PMC article. Review.
-
Molecular detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis.Front Med (Lausanne). 2024 Jun 7;11:1319845. doi: 10.3389/fmed.2024.1319845. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38912342 Free PMC article.
Cited by
-
Detection of Rifampicin Resistance rpoB Gene Using GeneXpert MTB/RIF Assay in Pulmonary Tuberculosis Cases at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia.J Clin Lab Anal. 2024 Nov;38(22):e25111. doi: 10.1002/jcla.25111. Epub 2024 Oct 10. J Clin Lab Anal. 2024. PMID: 39387506 Free PMC article.
-
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study.Trop Dis Travel Med Vaccines. 2024 Jul 1;10(1):15. doi: 10.1186/s40794-024-00224-1. Trop Dis Travel Med Vaccines. 2024. PMID: 38946006 Free PMC article.
-
Early detection of tuberculosis: a systematic review.Pneumonia (Nathan). 2024 Jul 5;16(1):11. doi: 10.1186/s41479-024-00133-z. Pneumonia (Nathan). 2024. PMID: 38965640 Free PMC article. Review.
-
Prevalence of Pulmonary Tuberculosis and Rifampicin Resistance Among Patients Attending Adama Hospital Medical College.Int J Microbiol. 2025 Feb 12;2025:1475396. doi: 10.1155/ijm/1475396. eCollection 2025. Int J Microbiol. 2025. PMID: 39974279 Free PMC article.
References
-
- Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
-
- Parija, Subhash Chandra (2012) Textbook of Microbiology and Immunology Second Edition. E-Book. URI: http://repository.poltekkes-kaltim.ac.id/id/eprint/1154
-
- Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
-
- Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
-
- Global tuberculosis report 2019. Geneva: World Health Organization; 2019. (https://www.who.int/tb/publications/global_report/en/).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources